Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review by Lanting, L.C. (Loes) et al.
Ethnic Differences in Mortality, End-
Stage Complications, and Quality of Care
Among Diabetic Patients
A review
LOES C. LANTING, MSC1
INEZ M.A. JOUNG, PHD1
JOHAN P. MACKENBACH, PHD, MD1
STEVEN W.J. LAMBERTS, PHD, MD2
AART H. BOOTSMA, PHD, MD2
OBJECTIVE— To determine the influence of ethnic differences in diabetes care on inequal-
ities in mortality and prevalence of end-stage complications among diabetic patients. The fol-
lowing questions were examined: 1) Are there ethnic differences among diabetic patients in
mortality and end-stage complications and 2) are there ethnic differences among diabetic pa-
tients in quality of care?
RESEARCH DESIGN AND METHODS— A review of the literature on ethnic differ-
ences in the prevalence of complications and mortality among diabetic patients and in the quality
of diabetes care was performed by systematically searching articles on Medline published from
1987 through October 2004.
RESULTS— A total of 51 studies were included, mainly conducted in the U.S. and the U.K.
In general, after adjusting for confounders, diabetic patients from ethnic minorities had higher
mortality rates and higher risk of diabetes complications. After additional adjustment for risk
factors such as smoking, socioeconomic status, income, years of education, and BMI, in most
instances ethnic differences disappear. Nevertheless, blacks and Hispanics in the U.S. and Asians
in the U.K. have an increased risk of end-stage renal disease, and blacks and Hispanics in the U.S.
have an increased risk of retinopathy. Intermediate outcomes of care were worse in blacks, and
they were inclined to be worse in Hispanics. Likewise, ethnic differences in quality of care in the
U.S. exist: process of care was worse in blacks.
CONCLUSIONS— Given the fact that there are ethnic differences in diabetes care and that
ethnic differences in some diabetes complications persist after adjustment for risk factors other
than diabetes care, it seems the case that ethnic differences in diabetes care contribute to the more
adverse disease outcomes of diabetic patients from some ethnic minority groups. Although no
generalizations can be made for all ethnic groups in all regions for all kinds of complications, the
results do implicate the importance of quality of care in striving for equal health outcomes among
ethnic minorities.
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D iabetes is one of the most commonchronic diseases in Europe and theU.S. (1–3). Diabetes is divided into
etiologic subclasses, of which type 1 and
type 2 are the most prevalent (4). The
prevalence of type 1 and, in particular,
type 2 diabetes is rising in all European
countries (2). Type 2 diabetes is the major
contributor to the epidemic rise in diabe-
tes because this type accounts for 90%
of diabetes. In the U.S., the overall prev-
alence of diabetes increased from 4.9% in
1990 to 6.5% in 1998 (5). There is a par-
allel rise in the prevalence of complica-
tions related to diabetes.
The prevalence of diabetes varies,
among other factors, by ethnicity. Several
studies (3,6,7) on ethnic differences in di-
abetes have reported higher prevalence
and incidence rates among ethnic minor-
ities. Furthermore, end-stage complica-
tions of diabetes have been reported to be
more common among ethnic minorities
(8–10), who also experience higher mor-
tality (11,12). However, research on eth-
nic di f ferences in morta l i ty and
complications among diabetic patients is
fragmented; a systematic overview is
missing.
Explanatory research of ethnic differ-
ences in general health has mainly fo-
cused on factors that are related to the
ethnic minorities directly, such as genetic,
socioeconomic, and sociocultural factors
(13). Another possible determinant of
ethnic health differences is health care it-
self, more specifically the accessibility and
the quality of health care (13). Although
health care alone cannot be expected to
eliminate ethnic inequalities in health
outcomes, it can potentially play an im-
portant role, especially for chronic dis-
eases for which prolonged and regular
treatment is required. Only a few studies
(14,15) have examined the role of quality
of care as a contributor to ethnic differ-
ences in health. For depression, another
chronic disease requiring prolonged and
regular treatment, it has been found that
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improving quality of care substantially re-
duced ethnic disparities (16).
Adequate treatment is important for
the management of diabetes and the pre-
vention of diabetes complications (17).
Although plausible, it is unknown
whether ethnic differences in quality of
care contribute to the explanation of eth-
nic differences in mortality and end-stage
complications among diabetic patients.
Therefore, a review of the literature was
performed in which the following re-
search questions were addressed: 1) Are
there ethnic differences among diabetic
patients in mortality and end-stage com-
plications and 2) are there ethnic differ-
ences among diabetic patients in quality
of care?
RESEARCH DESIGN AND
METHODS— We searched the Med-
line database for articles published be-
tween January 1987 and October 2004.
We used the keywords “ethnic ” and “di-
abetes” in combination with at least one of
the following: “quality of care,” “mortal-
ity,” “complications,” “cardiovascular dis-
ease,” “nephropathy,” “retinopathy,”
“lower extremity,” “end-stage renal dis-
ease,” “care,” “outcome,” or “HbA1c.”
The following inclusion criteria were
used. Studies in which ethnic minority
groups were compared with a white/
Caucasian majority group were included,
and studies with international compari-
sons (comparing ethnic groups of differ-
ent countries) were excluded. Only
studies restricted to diabetic populations
were included. Our interest was in ethnic
differences in the development of diabe-
tes complications and the risk of mortality
among diabetic patients and the effects of
their quality of care. In studies of ethnic
differences in diabetes complications per-
formed among the general population,
part of the ethnic differences is due to eth-
nic differences in the incidence of diabe-
tes, which is beyond the scope of our
report. Studies on patients with both type
1 and/or type 2 diabetes were included.
Studies that discussed ethnic differences
in a quantitative manner, e.g., by giving
relative risks, were included. Only mor-
tality studies in which all-cause mortality
rates were reported were included. We
restricted quality of care to the actual care
given (process). Studies about quality of
care in which access to care is investigated
were not covered.
The search produced 407 articles.
Screening titles and abstracts narrowed
this down to 85 articles. In a careful ex-
amination of these 85 manuscripts, 43
studies did not meet the inclusion criteria,
and this left us with 42 eligible articles for
our review. Then, we examined the bibli-
ographies of these articles, adding nine
articles to our list. Finally, a total of 51
studies were included. Appendix 1 of the
online appendix (available at http://
care.diabetesjournals.org) provides an
overview of the eligible studies for this
review indicating the ethnic groups and
outcomes involved.
Variables
Most studies included patients with both
type 1 and type 2 diabetes or did not ex-
plicitly state the type of diabetes of the
patients included in their study. Since the
majority of studies did not make a distinc-
tion between patients with type 1 or type
2 diabetes in the presentation of their out-
comes, we were unable to make this dis-
tinction in our review.
There is no universally accepted def-
inition of quality of care. For this review,
we focused on an important dimension of
care: actually delivered care. We adapted
an operational definition: whether the
care that individuals received was effec-
tive. Effectiveness is composed of the
structure, process, and outcome of care
(19). Structure of health care, referring to
the organizational factors, is the first as-
pect. On the whole, the structure is
mainly an indirect and contingent influ-
ence on care, especially when ethnic dif-
ferences in quality of care are studied
within hospitals and not between hospi-
tals. Although structural aspects can have
a direct impact on outcomes, we do not
think that they are the main reason of eth-
nic differences, and we decided to leave
them out of consideration (19). Process of
care is the actual delivery and receipt of
care, with technical interventions and in-
terpersonal interactions between users
and members of a health care system as
key processes. Process measures were or-
dered in five categories in order to assess
the quality of care: Test HbA1c (A1C; test
performing and treatment in case of poor
control), test blood pressure (test per-
forming and treatment in case of poor
control), eye examination, renal function
and lipid examination, and others (physi-
cian visits, dietary consultations) (20).
Outcomes are consequences of care. Mor-
tality and complications (lower-extremity
amputations, retinopathy, renal dysfunc-
tion, cardiovascular disease, and neurop-
athy) are considered as long-term
outcomes, while outcome measures like
A1C and blood pressure, for instance, are
considered intermediate outcomes of
care. We included all ethnic groups, but
in practice, the diversity is restricted to a
few main groups. The different ethnic
groups were categorized into four catego-
ries (Table 1) for ease of analysis.
Table 1—Summary table
Cover
terminology Ethnic minority groups
Number of
studies
Outcomes
Mortality Complications
Intermediate
outcomes
Process of
care
Black African American, black, non-Hispanic
black, African Caribbean
39 6 18 9 15
Hispanic Mexican American, Latino, Hispanic,
Hispanic American
19 1 10 4 6
Asian Asian, Indo Asian, South Asian 9 1 7 — 1
Other Native American, Algerian, other ethnicity 5 1 3 — 2
Summary of categories of ethnic minority groups and the number of studies in which the specific outcomes have been studied for each of the ethnic categories. The
majority group consisted of Caucasians or non-Hispanic whites.
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Analysis
We analyzed the data successively for
mortality, complications of diabetes, in-
termediate outcomes of care, and quality
of care. In the different studies included
in this review, there was a large variation
in the (number of) variables for which ad-
justments were made. To determine
whether any ethnic differences existed be-
tween diabetic patients and mortality and
end-stage complications (research ques-
tion 1), we started to assess studies in
which only adjustments were made for
confounders. Only three factors were
considered as confounders: age, sex, and
duration of diabetes. Other factors (such
as socioeconomic status, smoking, and
health insurance) that can act as interme-
diaries in the causal chain between ethnic
background and diabetes outcomes were
considered as risk factors. Studies in
which adjustment is made for such risk
factors could, indirectly, shed some light
on the question of whether quality of care
has the potential to decrease ethnic differ-
ences in mortality and end-stage compli-
cations among diabetic patients. If ethnic
differences disappear after controlling for
other risk factors, there is no need to focus
further on ethnic differences in quality of
care as a possible explanation. On the
other hand, if there has been extensive
control for other risk factors and ethnic
differences in diabetes complications and
mortality still persist, there is room for
quality of care to play a role in the expla-
nation of the remainder of the ethnic dif-
ferences in diabetes outcomes. Therefore,
the outcomes of the studies of this review
are described in two steps. First, the out-
comes of studies after adjustment for con-
founders are assessed in order to determine
whether there are ethnic differences
among diabetic patients in mortality, end-
stage complications, and intermediate
outcomes of care. Second, the outcomes
of studies are assessed after adjustment
for risk factors of adverse diabetes com-
plications other than the quality of care
(e.g., educational level, obesity status,
smoking, income). Throughout the arti-
cle, adjustment for these risk factors is re-
ferred to as a “more comprehensive
adjustment” besides the “basic adjustment ”
for confounders. In studies where more
comprehensive adjustment for risk factors
was made, we evaluated whether ethnic dif-
ferences that could be attributed to ethnic
differences in health care remained.
RESULTS
Ethnic differences in mortality and
diabetes complications
Mortality. In Table 2, the outcomes of
studies on ethnic differences in mortality
are shown. In Tables 2–5, a single study
addressing several ethnic groups (and/or
several outcome variables) could contrib-
ute more than one sign. That also applies
for studies with stepwise adjustment for
confounders and risk factors. Since there
were only a few studies that investigated
more than one minority group or out-
come variable or that made stepwise ad-
justments, nearly each sign represents
one study. A more detailed overview of
mortality and morbidity data are given in
appendix 2 of the online appendix.
Five U.S. studies (12,21–24) reported
higher mortality rates among ethnic mi-
norities, after adjustment for confound-
ers. In one study (22), the ethnic
differences in black versus white disap-
peared after adjustment for additional
risk factors like income and cigarette
smoking. In another study, the ethnic dif-
ferences persisted for U.S.-born Mexican
Americans after adjusting for risk factors
like smoking status and blood pressure.
However, after additional adjustment for
more risk factors like disease severity, the
differences disappeared (24).
Two U.K. studies (11,25) reported,
on the contrary, lower mortality rates
among blacks after adjusting for age, sex,
and BMI, which was no longer statistically
significant after adjustment for additional
risk factors (25). One U.K. study (26),
which was adjusted for sex, age, and du-
ration of diabetes, reported no differences
in mortality rates between Asians and
whites. A New Zealand study (27)
showed higher mortality rates for Maori
people but no differences for inhabitants
of the Pacific Islands.
After adjusting for confounders,
higher mortality rates were found among
blacks in the U.S. but lower rates among
blacks in the U.K. After adjusting for
other risk factors, besides age and sex, no
ethnic differences in mortality were found
in most studies.
Complications
Lower-extremity amputations. In four
U.S. studies (8,10,28,29) in which no ad-
justments, apart from age and/or sex,
were made, higher risks of lower-
extremity amputation (LEA) were re-
ported among ethnic minorities (Table 3).
In other studies, in which more compre-
hensive adjustments were made, risks for
ethnic groups were different compared
with studies only adjusting for confound-
ers. For blacks, increased risks were seen
in two studies (30,31), whereas in four
other studies (28,32–34) no differences
were reported. In two studies among
Asians (30,33), in which comprehensive
adjustments were used, a decreased risk
of LEA was reported. For Hispanics, re-
sults were more contradictory. One study
(8), only adjusted for age, showed a lower
risk. In other studies on Hispanics, after
adjusting for additional factors, equal risk
was reported in two studies (32,33) and
increased risk in two studies (29,30). Na-
tive Americans have a higher risk of LEA;
one study (30) reported an increased risk
after adjusting for several risk factors be-
sides age and sex.
Table 2—Ethnic differences inmortality (referencewhites) reported by included studies (parts
of studies)
Region
No
adjustment
Adjusting for
confounders
Adjusting for
additional
risk factors
U.S.
Black     
Hispanic      
U.K.
Black   
Asian 
Other  
Outcomes are coded as, worse situation and higher mortality;, no difference in mortality; and, better
situation and lower mortality. Studies addressing several outcome variables and/or ethnic groups or studies
making stepwise adjustment for confounders and risk factors could contribute more than one sign to the
table.
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In two U.K. studies (35,36), one
without adjustment and another adjust-
ing for only age and sex, lower risks for
LEA were reported among blacks and
Asians. The lower risk for blacks disap-
peared after adjusting for risk factors such
as smoking and neuropathy (35). After
adjustment for confounders (age and
sex), most ethnic minorities in the U.S.
have increased risks of LEA, which are
absent after a more comprehensive ad-
justment for risk factors.
Retinopathy
After adjusting for confounders, blacks as
well as Hispanics had a higher risk of ret-
inopathy in the U.S. (32). In studies with
more comprehensive adjustments, the
risk of retinopathy for blacks in the U.S.
was conflicting: three studies reported
equal risks of retinopathy (9,37,38), one
reported a lower risk (39), and one dem-
onstrated a higher risk for developing
progressive retinopathy (40). In other
studies, in which only adjustments for
risk factors were performed, risk for His-
panics (Mexican Americans) was higher
than for whites in two studies (9,41),
whereas one study (42) noted a smaller
risk.
In the U.K., blacks had an equal risk
of retinopathy after adjustment for age
(25), and Asians had a lower risk after
adjustment for risk factors like smoking
or treatment (43). In France, Algerian im-
migrants had equal risk of retinopathy
compared with French people after
matching for sex and duration of diabetes
(44). Generally, ethnic minorities in the
U.S. seem to have a higher risk of retinop-
athy. After adjusting for risk factors, re-
sults are inconsistent for blacks. Only the
higher risk for Hispanics persists.
Cardiovascular disease
Cardiovascular complications included
coronary heart disease, myocardial infarc-
tion, stroke, and congestive heart failure.
After adjustment for confounders, one
U.S. study (32) reported equal risks of
cardiovascular diseases for blacks and
Hispanics. After adjustments for risk fac-
tors in another study (33), Asians and
Hispanics had a lower risk, while an equal
risk for blacks remained.
Two U.K. studies (25,43) reported a
lower risk of cardiovascular disease in
blacks and Asians, although Asians had
an equal risk for heart vascular diseases
(angina and myocardial infarction). Over-
all, a lower risk of cardiovascular disease
was reported for ethnic minorities.
Renal complications (nephropathy
and end-stage renal disease)
In the U.S., the risk of end-stage renal
disease (ESRD) is reported to be higher
among Hispanics and blacks than among
whites (45,46), after adjusting for con-
founders. One study reported equal risk
Table 3—Ethnic differences in diabetes complications (reference whites) reported by included
studies (parts of studies)
Complication
No
adjustment
Adjusting for
confounders
Adjusting for
additional risk
factors
LEA
U.S.
Black           
Hispanic      
Asian  
Other  
U.K.
Black  
Asian 
Retinopathy
U.S.
Black      
Hispanic     
U.K.
Black 
Asian 
Other
Other 
Nephropathy and ESRD
U.S.
Black      
Hispanic    
Asian 
U.K.
Black 
Asian  
Other
Asian 
Other 
Cardiovascular complications
U.S.
Black     
Hispanic     
Asian   
U.K.
Black 
Asian  
Neuropathy
U.S.
Black  
Hispanic  
Other
Other 
Outcomes are coded as, worse situation and increased/higher risk;, the same situation and no different
risk; and, better situation and decreased/lower risk. Studies addressing several outcome variables and/or
ethnic groups or studies making stepwise adjustment for confounders and risk factors could contribute more
than one sign to the table.
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(32). In studies with adjustments for risk
factors, equal risks for blacks are noted in
one study (38), while two studies (33,47)
noted an increased risk for blacks. Asians
were reported to have a higher risk of
ESRD, and for Hispanics conflicting re-
sults were reported. One study (42) re-
ported an equal risk, and an increased risk
was mentioned in another study (33).
Two U.K. studies (43,48) reported
higher rates of ESRD among Asians, and
one study (25) found no differences be-
tween blacks and whites in proteinuria.
Asians had an increased risk in a Dutch
study (49), and a French study (44) re-
ported no ethnic differences among Alge-
rians who were living in France. In
conclusion, ethnic minorities showed a
higher risk of ESRD than whites, espe-
cially blacks and Asians. After adjusting
for risk factors, the higher risk remains.
Neuropathy
No ethnic differences were reported in
risk of neuropathy in the U.S. for blacks
or Hispanics (32,38,42). On the other
hand, a French study (44) has reported a
higher risk of neuropathy among Algeri-
ans in France.
Ethnic differences in intermediate
outcomes of care
In 13 studies (14,15,50 –56), all per-
formed in the U.S., intermediate out-
comes of diabetes care are discussed
(Table 4). In nine studies (14,50 –
55,57,58), worse levels of outcomes (e.g.,
higher A1C, higher risk of hypertension)
are reported among ethnic minorities
(i.e., Hispanics, African Americans,
blacks). Most studies among blacks
(14,50 –55,57,58) reported worse out-
comes, whereas two studies (59,60) re-
port only worse outcomes among black
women but no differences for men. An
interventional study (56) showed no dif-
ference in the outcomes neither before
nor after the intervention took place. The
majority of studies (15,50,51,53–55,57–
60) about blacks adjusted for several fac-
tors. Only two studies (14,52) did not
adjust at all, with similar results com-
pared with the adjusted studies. For His-
panics, one (unadjusted) study (14)
reported worse glycemic control and a
higher risk for clinical proteinuria. Two
other studies, after adjusting extensively,
reported different outcomes in glycemic
control. One study (60) demonstrated no
ethnic differences in glycemic control,
while another study (50) showed worse
control among Hispanics. Overall, inter-
mediate outcomes of care were worse in
blacks, and outcomes among Hispanics
were inclined to be worse.
Ethnic differences in quality of care
Results of ethnic differences in quality of
care (process of care) are shown in Table
5. In this table, a lot of studies investigated
more than one process measure. That im-
plies that in this table, in contrast with the
previous tables, one study contributed,
on average, more than one sign. Overall,
15 studies concerning ethnic differences
in quality of care were included, all of
which were performed in the U.S. As pre-
viously mentioned, we restricted our-
selves to process of care. Indicators were
mainly the frequency of several preven-
tive tests for treatment of diabetes. Two
studies only took the frequency of eye
care tests into account, whereas other
studies assessed several tests simulta-
neously. In five studies (15,32,50,55,61),
higher quality for ethnic minorities for at
least one indicator was reported, but eight
studies (14,38,51–53,62– 64) reported
an overall lower quality for ethnic minor-
ities in process of care. The only interven-
tion study (56) included in this review
showed lower quality for ethnic minori-
ties before the intervention was imple-
mented, and after the intervention,
differences disappear. Blacks especially
scored lower on one or more indicators
(14,38,51–53,62– 64). One study (54)
reported equal quality of care (process of
care) for blacks, and three studies (15,
32,55) noted predominantly a higher
quality of care for blacks. For Hispanics,
two studies (32,54) reported equal qual-
ity of process of care, two studies (14,64)
reported lower quality, and one study
(50) higher quality. One study (61) in-
volved non-English–speaking Asians
(56% of the Asians compared with 7% of
whites were non-English speaking). Non-
English–speaking diabetic patients were
receiving higher quality of process of care.
Overall, process of care was worse for
blacks and Hispanics.
Relationship between quality of care
and diabetic morbidity and mortality
Studies in which both quality and out-
comes of care (intermediate outcomes,
morbidity, and/or mortality) are mea-
sured and where associations between
both factors have been analyzed would
provide a direct opportunity to determine
the influence of ethnic differences in dia-
betes care on inequalities in diabetes out-
comes. Many studies (14,15,50–55) have
investigated quality of care and interme-
diate outcomes of care. Unfortunately,
with the exception of four studies (14,
53,55,56), most research has treated the
measurements separately and not ana-
lyzed the associations. The first study (53)
examined several factors that may explain
why black patients, compared with
whites, have worse intermediate out-
comes (glycemic control). Process of care
is considered as a determinant, and three
indicators were investigated: control of
cholesterol, control of blood pressure,
and reporting of a flu shot in the past year.
One indicator, receiving a flu shot, was
associated with glycemic control. Not re-
ceiving flu shots is related to worse glyce-
Table 4—Ethnic differences in intermediate outcomes of care (reference whites) measured by
separate indicators and reported by included studies (parts of studies), all U.S. studies
Intermediate outcome No adjustment
Adjusting for
confounders
Adjusting for
additional
risk factors
A1C
Black        
   
Hispanic   
Other
Black                
Hispanic        
Outcomes are coded as , worse outcome regarding one indicator; , equal outcome regarding one
indicator; and , better outcome regarding one indicator. Studies addressing several outcome variables
and/or ethnic groups or studies making stepwise adjustment for confounders and risk factors could con-
tribute more than one sign to the table.
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mic control. This supports the notion that
a higher quality of care is associated with
better glycemic control. However, in this
study, no ethnic differences in glycemic
control were found. In the second study
(55), process of care (frequencies of tests:
e.g., A1C) of African Americans and Cau-
casians were compared. The finding that
African Americans were in poorer meta-
bolic control than Caucasians led to the
analysis of the relationship of glycemic
control to determine test frequency per
group. There were no ethnic differences
in the frequency of testing for A1C. Afri-
can Americans were more likely to have a
cholesterol or creatinine test. Those in
poorer control tended to have a low num-
ber of tests. The third study reported no
association between outcomes of care and
process of care (one indicator: the num-
ber of physician visits per year), with a
few exceptions. Hypertensive blacks with
six or more visits in the previous year
were more likely to have a blood pressure
140/90 mmHg compared with those
with less than six visits (14). So, these
studies do not suggest ethnic differences
in outcomes caused by ethnic differences
in process of care. The fourth study is an
intervention study in which an interven-
tion to improve health care was imple-
mented, focusing on ethnic populations.
The intervention had three foci. Partly, it
consisted of improvements of quality of
care. Two years after the implementation,
ethnic differences in the process of care
had disappeared (56). Two studies (32,
38) investigated the quality of care and
subsequent morbidity and/or mortality.
In these studies, no analyses were con-
ducted to assess the relationship between
quality of care and/or morbidity.
CONCLUSIONS— After adjusting
for confounders, the literature shows that
diabetic patients from ethnic minorities
have higher mortality rates and a higher
risk of diabetes complications. After addi-
tional adjustment for risk factors like
smoking, socioeconomic status, income,
years of education, and BMI, in most in-
stances, ethnic differences disappear.
Nevertheless, among U.S. blacks and His-
panics and among U.K. Asians, an in-
creased risk of ESRD is seen, and blacks
and Hispanics in the U.S. have an in-
creased risk of retinopathy. Intermediate
outcomes of care are worse in blacks, and
outcomes among Hispanics were also in-
clined to be worse. Likewise, ethnic dif-
ferences in the quality of care in the U.S.
exist: process of care is worse among
blacks.
Several limitations of this review need
to be mentioned before the findings are
discussed. A common problem in a re-
view is the comparability of the studies
included. In our review, comparability
may be limited by a lack of a clear defini-
tion of ethnic groups and the outcome
measures (especially measures of the
quality of care), a clear description of type
of diabetic patient included in the study,
and heterogeneity in the age range and the
source population of the patients.
First, the lack of a clear definition of
ethnicity makes it difficult to compare
ethnic groups in a reliable way. Mexican
Americans and Hispanics belong partly to
the same ethnic group, but studies in-
cluded probably one of the two without
giving a more precise definition. Creating
subgroups of black and white Hispanics,
without specifying the definition, makes
it more complex to separate whites,
blacks, and Hispanics from each other.
A clear definition of outcome mea-
sures, especially for quality of care, was
missing in most studies. Only a few stud-
ies discussed the criteria for quality in an
explicit way. The lack of definitions of
quality or operational definitions makes it
difficult to compare studies regarding
quality of care. To investigate the impor-
tance of quality of care for ethnic dif-
ferences in diabetes outcomes, it is
important that future research describes
how quality of care is defined and opera-
tionalized. Besides, in most studies, qual-
ity of care was not investigated. For these
studies, we infer the possible meaning of
quality of care by assessing the explana-
tion of ethnic differences by factors other
Table 5—Ethnic differences in process of care (reference whites) measured by separate indi-
cators and reported by included studies (parts of studies), all U.S. studies
Process of care No adjustment
Adjusting for
confounders
Adjusting for
additional risk
factors
Test A1C
Black           
  
Hispanic      
Asian 
Other
Blood pressure
Black     
Hispanic     
Asian
Other
Eye exam
Black         
Hispanic  
Asian 
Other
Lipids and renal function
Black                
Hispanic        
Asian   
Other
Other
Black                
 
Hispanic        
Asian  
Other 
Outcomes are coded as, worse quality regarding one indicator;, equal quality regarding one indicator;
and , better quality regarding one indicator. Studies addressing several outcome variables and/or ethnic
groups or studies making stepwise adjustment for confounders and risk factors could contribute more than
one sign to the table.
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than quality of care. However, most stud-
ies did correct for confounders and/or
other factors, but only a few studies cor-
rected for confounders in the beginning
and subsequently extended the adjust-
ment with risk factors. The last method-
ology would have produced results
concerning the influence of quality of care
on ethnic differences in outcomes. In the
absence of these types of studies, we had
to infer the explanations from different
factors between different studies. In addi-
tion, the inclusion of different types of
diabetes further complicated the prepara-
tion of this review. About half of the stud-
ies gave a description of the type of
diabetes included. Studies included type
1 and/or type 2 diabetes. Almost none of
the studies, which included both types of
diabetes, investigated in the analyses the
role of the different types of diabetes on
the outcomes. Two studies (45,47) re-
ported different relative risks of ESRD for
insulin-dependent diabetes (type 1 diabe-
tes) and non-insulin–dependent diabetes
(type 2 diabetes) separately. The relative
risks for blacks versus whites in the two
studies for type 1 diabetes was 0.90 and
1.03, respectively, and for type 2 diabetes,
the risk was significantly increased to
4.80 and 4.31. Based on only two studies,
we cannot determine ethnic differences in
outcomes regarding the type of diabetes.
Finally, the comparability of studies is
complex because some studies used na-
tional data while others used data from
one hospital. We did not give a higher
weight to the results of a national study
with large populations (55) in compari-
son with results based on a smaller pop-
ulat ion in one sett ing (49). The
methodological issues with regard to the
comparability of the studies only allow us
to draw tentative conclusions.
We noticed differences between the
results of studies conducted in the U.S.
and studies conducted in the U.K. In
many U.S. studies, ethnic minorities were
found to have increased risks for mortal-
ity and diabetes complications, whereas
in many U.K. studies, ethnic minorities
were reported to have lower or equal risks
in comparison with the white majority.
Ethnic minority groups in the U.S. and
U.K. are partly different. Asians in the
U.S. mainly originate from countries as
China and Japan, while Asians in the U.K.
mostly originate from India and Pakistan.
Blacks in the U.S. and blacks in the U.K.
have, although both originating from Af-
rica, different migration histories. How-
ever, with regard to this last group, it was
remarkable that blacks in the U.S. have an
increased risk of mortality and diabetes
complications, whereas in the U.K.,
blacks had lower risks. These differences
cannot be attributed to genetic differ-
ences. Although cultural differences be-
tween blacks living in the U.S. and U.K.
could be an explanation, health care dif-
ferences between these countries could
also be a probable explanation. Access to
care in the U.K., with its National Health
Service, is more equal than in the U.S.
(65). It is also possible that differences in
the quality of care exist between these
countries, with the quality of care in the
U.K. being more equal among ethnic
groups than in the U.S. Unfortunately, the
studies on ethnic differences in quality of
care all originated from the U.S., and,
consequently, we are not able to study
this assumption further.
Further, we did not take ethnic-
specific guidelines into account and as-
sumed that optimally, the process of care
should be the same for all ethnic groups.
This is debatable because the process of
care is based on guidelines with overall
less attention for specific clinical circum-
stances. Specific clinical circumstances
usually refer to the age and sex of the pa-
tient. In ethnic minority groups, particu-
lar diseases can be more prevalent or
more severe, and this may also determine
the patient’s clinical circumstances. Igno-
rance of ethnic differences between pa-
tients could lead to inferior quality of care
for ethnic minorities (66).
We found no studies in which the role
of quality of care in the explanation of
ethnic differences in mortality and diabe-
tes complications was empirically tested.
However, recently a study (56) showed
that by improving (in a broad approach
with three different main foci) the quality
of care, ethnic differences in process of
care disappeared. Further, there are sev-
eral indirect indications that the quality of
care might be of importance. In studies in
which extensive adjustment was made for
other risk factors except the quality of
care, e.g., by adjusting for patient and so-
cioeconomic characteristics, for several
outcome measures ethnic differences in
the outcomes remained present. Differ-
ences in risk of retinopathy and ESRD
mainly persisted for blacks and Hispanics
after adjustment. Because adjustments
were made for a wide range of variables,
except for quality of care, it is plausible to
state that quality of care might play a role.
Additionally, although there were no
studies in which adjustment was made for
quality of care, there were several studies
in which adjustment was made for inter-
mediate outcomes of care. While studies
adjusted for confounders demonstrate the
presence of ethnic differences, subse-
quent adjustment for intermediate out-
comes of medical care, like hypertension,
A1C levels, cholesterol levels, and pro-
teinuria, result in no ethnic differences in
long-term diabetes outcomes (22,25,28,
35). To elaborate on this, outcomes of
medical care have a direct influence on
morbidity and mortality; therefore, it can
be concluded that the quality of this care
plays an important role.
We did not investigate the reasons for
ethnic differences in the quality of care,
but recently, a U.S. study explored the
reasons why black patients received low-
er-quality health care than white patients.
Black patients and white patients are to a
large extent treated by different physi-
cians. The physicians treating black pa-
tients may be less well trained clinically
and may have less access to important
clinical resources than physicians treating
white patients. To a certain extent, these
differences may have lead to disparities in
the outcomes (67). Other reasons could
be racism (68), physicians’ perceptions of
patients (69), preferences of the patients
(70,71), or the patient-caregiver relation-
ship (72).
We conclude that, especially for
blacks and Hispanics in the U.S., differ-
ences in outcomes can decrease by im-
proving the quality of care. For the U.K.,
only Asians have a higher risk of ESRD,
and the influence of quality of care on this
result is less convincing than in the U.S.
There is no general pattern in risks of
complications or mortality for ethnic mi-
norities as a whole. The diversity in risks
of the several diabetes complications in
ethnic groups, combined with the differ-
ent results for the U.S. and the U.K., does
not allow us to generalize the results to
other regions or other ethnic groups.
However, the results indicate that quality
of care is an important factor among eth-
nic minority groups.
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